Caption Management’s Edwards Lifesciences EW Stock Holding History

Caption Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,012	Closed	-$548K	–	1776
2025 Q2	$548K	Buy	+7,012	New	+$523K	0.01%	1089
2024 Q3	–	Sell	-14,000	Closed	-$1.02M	–	1382
2024 Q2	$1.29M	Buy	+14,000	New	+$1.24M	0.02%	599
2023 Q4	–	Sell	-47,800	Closed	-$3.33M	–	1429
2023 Q3	$3.31M	Buy	+47,800	New	+$3.84M	0.05%	445
2023 Q1	–	Sell	-15,000	Closed	-$1.12M	–	1226
2022 Q4	$1.12M	Buy	+15,000	New	+$1.16M	0.02%	711
2022 Q1	–	Sell	-200	Closed	-$27K	–	1603
2021 Q4	$27K	Sell	200 -71,700	-100%	-$8.36M	﹤0.01%	1526
2021 Q3	$8.14M	Buy	71,900 +16,900	+31%	+$1.93M	0.09%	288
2021 Q2	$5.7M	Buy	+55,000	New	+$5.18M	0.07%	344
2018 Q1	–	Sell	-32,250	Closed	-$1.21M	–	247
2017 Q4	$1.21M	Buy	+32,250	New	+$1.18M	0.13%	164

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Caption Management's EW Position: Q3 2025 in Review

Caption Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 7,012 shares — an estimated $548K sold.

Caption Management first reported a position in EW in Q4 2017 and held it in 8 quarters. The position peaked at $8.14M in Q3 2021. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Caption Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Caption Management sold 7,012 Edwards Lifesciences shares in Q3 2025, an estimated $548K.
Caption Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 8 quarters.
Caption Management's Edwards Lifesciences position peaked at $8.14M in Q3 2021.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.